Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd Share Price Today: Live Updates & Key Insights

Get insights on Mangalam Drugs and Organics Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Mangalam Drugs and Organics Ltd Share Price Chart

Mangalam Drugs and Organics Ltd Fundamentals

Traded Volume: 1,68,816

Market Cap(Cr): 73

Avg Traded Price 46.13

1 Year return -55.36%

Upper Circuit 49.1

Lower Circuit 44.5

P/E TTM -4.00

P/B Ratio -12.00

Traded Value(Cr) 78.31

EPS TTM -12.270

Book value -12.270

Dividend 0.00%

Mangalam Drugs and Organics Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Mangalam Drugs and Organics Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Mangalam Drugs and Organics Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -25.12%

1M -33.48%

3M -42.52%

1Y -55.36%

YTD -59.62%

Mangalam Drugs and Organics Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Mangalam Drugs and Organics Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 3.88L

Day Before Yesterday 1.48L

1W Avg 1.18L

1M Avg 46782.90

3M Avg 31950.45

Mangalam Drugs and Organics Ltd Technical Details

Mangalam Drugs and Organics Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 44

Support 2 42

Support 3 40

Pivot Point : 47

Resistance 1 49

Resistance 2 51

Resistance 3 53

Mangalam Drugs and Organics Ltd Corporate Actions

Mangalam Drugs and Organics Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Mangalam Drugs and Organics Ltd’s capital allocation strategies.

All

Ex-Date 21-Dec-2017 Type D Description 0.50/share@5.00% Record Date 22-Dec-2017 Ratio 5.00

Dividends

Announcement Date 21-Dec-2017 Ex Dividend Date 21-Dec-2017 Dividend(%) 5

Bonus

No Bonus has been declared by MANGALAM

Splits

No Split has been declared by MANGALAM

Others

Rights No Rights has been declared by MANGALAM

Mangalam Drugs and Organics Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Mangalam Drugs and Organics Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Mangalam Drugs and Organics Ltd's relative performance and valuation against major competitors.

Stock Name Samrat Pharmachem Ltd ₹270.10 (-1.48%) M. Cap (Cr) 0.83 1 Yr Return (%) -39.49% P/E (TTM) 53.17 PB Ratio 1.16

Stock Name Concord Drugs Ltd ₹79.10 (-2.77%) M. Cap (Cr) 0.79 1 Yr Return (%) +121.32% P/E (TTM) 137.01 PB Ratio 2.33

Stock Name Makers Laboratories Ltd ₹130.00 (+2.52%) M. Cap (Cr) 0.77 1 Yr Return (%) -19.30% P/E (TTM) -3518.27 PB Ratio 1.09

Stock Name Mangalam Drugs and Organics Ltd ₹46.39 (-4.01%) M. Cap (Cr) 0.73 1 Yr Return (%) -55.36% P/E (TTM) -3.78 PB Ratio 0.49

Stock Name Sunil Healthcare Ltd ₹71.60 (+0.96%) M. Cap (Cr) 0.73 1 Yr Return (%) -4.52% P/E (TTM) 40.98 PB Ratio 1.05

Stock Name Welcure Drugs & Pharmaceuticals Ltd ₹0.58 (+3.57%) M. Cap (Cr) 0.72 1 Yr Return (%) -20.55% P/E (TTM) 2.06 PB Ratio 0.57

Stock Name Asston Pharmaceuticals Ltd ₹84.00 (-2.33%) M. Cap (Cr) 0.72 1 Yr Return (%) NaN% P/E (TTM) 16.53 PB Ratio 5.52

Mangalam Drugs and Organics Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Mangalam Drugs and Organics Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 42.92 Mar 2024 12.17 Mar 2023 39.52 Mar 2022 25.71 Mar 2021 27.55

PARTICULARS Investing Activities Mar 2025 19.47 Mar 2024 -17.90 Mar 2023 -22.17 Mar 2022 -27.33 Mar 2021 -31.29

PARTICULARS Financing Activities Mar 2025 -21.71 Mar 2024 5.70 Mar 2023 -16.62 Mar 2022 2.98 Mar 2021 2.70

PARTICULARS Net Cash Flow Mar 2025 42.26 Mar 2024 -0.04 Mar 2023 0.73 Mar 2022 1.36 Mar 2021 -1.04

Mangalam Drugs and Organics Ltd Shareholding Pattern

This shows the ownership breakdown of Mangalam Drugs and Organics Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 50.3%

Public 49.57%

Other Institutions 0.0%

FII 0.11%

Mutual Funds null%

About Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001. The company was promoted by Dhoot family. The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra. They also have an in-house Research and Development (R&D) Base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, and dyes and intermediaries. In April 1, 1996 three other group companies, namely Mangalam Organics Pvt Ltd, Shree Mangalam Pharma Pvt Ltd and Mangalam Rasayan Pvt Ltd were amalgamated with the company. In the year 1999, the company launched a new product namely, Nimesulide. In the year 2001, they launched two new products namely Amodiaquine Hydrochloride and Amodiaquine. In the year 2003-2004, the bulk drug production capacity of the Company was increased from 350 MTPA to 600 MTPA. During the 2004-05, the capacity is being further enhanced to 960 MTPA. During the year 2005-06, the company further enhanced their Bulk drug production capacity from 960 MT per annum to 1260 MT per annum. During the year 2007-08, the company developed and introduced new bulk drugs namely Bisoprolol Fumarate and Pantaprazole Sodium. Also, they increased the production capacity of Meta Chloro Aniline & Allied Products from 250 tons to 350 tons. During the year 2009-10, the company in addition to Regulatory Affairs Cell established Intellectual Property Rights (IPR) cell. The regulatory affairs cell submitted 6 DMFs to WHO-Geneva out of which 2 DMFs corresponding to Artemether and Lumefantrine had been approved. During the year 2017-18, Unit 2 of the Company received WHO Approvals for manufacturing of the Active Pharmaceutical ingredients comprising of Lumefantrine (APIMF100); Tenofovir Disoproxil Fumarate (APIMF204); Artemether (APIMF138); Emtricitabine (WHO API314); Efavirenz (WHO API 318).

Chairman & Managing Director

Govardhan M Dhoot

Registered office 3rd Floor Rupam Building, 239 P D Mello Road, Mumbai, Maharashtra, 400001

FAX :91-22-22616200/6300/8787

Background

Incorporation Year 1972

Face Value ₹10.00

Market Lot 1

Mangalam Drugs and Organics Ltd Latest News

VIEW MORE NEWS

FAQs on Mangalam Drugs and Organics Ltd